Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20279 | 26047899 | Int J Biol Macromol | Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms. | 2015 | Details |
| A20280 | 26047766 | Clin Nutr | Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial. | 2015 | Details |
| A20281 | 26047682 | Diabetes Res Clin Pract | Volume-dependent effect of supervised exercise training on fatty liver and visceral adiposity index in subjects with type 2 diabetes The Italian Diabetes Exercise Study (IDES). | 2015 | Details |
| A20282 | 26046667 | Eur J Clin Invest | Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38). | 2015 | Details |
| A20283 | 26046396 | Nutrients | Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis. | 2015 | Details |
| A20284 | 26045709 | Hepat Mon | Saturated Fatty Acid inhibits viral replication in chronic hepatitis B virus infection with nonalcoholic Fatty liver disease by toll-like receptor 4-mediated innate immune response. | 2015 | Details |
| A20285 | 26045704 | Hepat Mon | Clinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis. | 2015 | Details |
| A20286 | 26045616 | Am J Physiol Gastrointest Liver Physiol | Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation. | 2015 | Details |
| A20287 | 26045281 | Dig Dis | Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH? | 2015 | Details |
| A20288 | 26045279 | Dig Dis | Use of farnesoid X receptor agonists to treat nonalcoholic fatty liver disease. | 2015 | Details |
| A20289 | 26045268 | Dig Dis | Relationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development. | 2015 | Details |
| A20290 | 26043560 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Treating non-alcoholic fatty liver disease patients of Gan stagnation Pi deficiency syndrome by tiaogan lidi recipe: a randomized controlled clinical trial]. | 2015 | Details |
| A20291 | 26043290 | Eur J Gastroenterol Hepatol | Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20292 | 26042770 | PLoS One | mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC). | 2015 | Details |
| A20293 | 26042596 | PLoS One | Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes. | 2015 | Details |
| A20294 | 26042518 | Metab Syndr Relat Disord | Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study. | 2015 | Details |
| A20295 | 26041952 | J Clin Exp Hepatol | Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications. | 2015 | Details |
| A20297 | 26040363 | Nutr Hosp | Effect of the intake of liquids rich in polyphenols on blood pressure and fat liver deposition in rats submitted to high-fat diet. | 2015 | Details |
| A20298 | 26040357 | Nutr Hosp | Predictive factors of non-alcoholic steatohepatitis: relationship with metabolic syndrome. | 2015 | Details |
| A20300 | 26039829 | Arq Gastroenterol | Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome. | 2016 | Details |
| A20301 | 26039828 | Arq Gastroenterol | Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area. | 2016 | Details |
| A20302 | 26039731 | PLoS One | Intravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice. | 2015 | Details |
| A20303 | 26039004 | Turk J Gastroenterol | A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population. | 2015 | Details |
| A20305 | 26038701 | Pharmacol Res Perspect | Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. | 2015 | Details |
| A20308 | 26036873 | Electrophoresis | Comparative proteomic analysis using 2DE-LC-MS/MS reveals the mechanism of Fuzhuan brick tea extract against hepatic fat accumulation in rats with nonalcoholic fatty liver disease. | 2015 | Details |
| A20309 | 26035752 | Int J Mol Sci | Effect of Chronic Pioglitazone Treatment on Hepatic Gene Expression Profile in Obese C57BL/6J Mice. | 2015 | Details |
| A20311 | 26035386 | Dis Model Mech | Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice. | 2015 | Details |
| A20312 | 26034364 | World J Gastroenterol | Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. | 2015 | Details |
| A20313 | 26033743 | J Nutr Biochem | Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease. | 2015 | Details |
| A20314 | 26033364 | Exp Cell Res | MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression. | 2015 | Details |
| A20315 | 26033245 | Mol Cell Endocrinol | Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet. | 2015 | Details |
| A20316 | 26032587 | Pharmacol Res | Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial. | 2015 | Details |
| A20317 | 26031974 | Clin Med (Lond) | MTHFR 677C/T and 1298A/C mutations and non-alcoholic fatty liver disease. | 2015 | Details |
| A20318 | 26031832 | Curr Gastroenterol Rep | A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease. | 2015 | Details |
| A20319 | 26031413 | Hepatol Res | Emodin ameliorates hepatic steatosis through endoplasmic reticulum-stress sterol regulatory element-binding protein 1c pathway in liquid fructose-feeding rats. | 2015 | Details |
| A20320 | 26031147 | Klin Med (Mosk) | [Metabolic disorder and polymorphism of the genes encoding for beta-2-adrenergic receptor and apolipoproteins B in chronic hepatitis C and non-alcoholic fatty liver diseases]. | 2015 | Details |
| A20321 | 28210688 | Cell Mol Gastroenterol Hepatol | Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. | 2015 | Details |
| A20322 | 26028579 | Gastroenterology | Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20324 | 26028044 | Curr Drug Targets | Natural Products on Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20325 | 26028042 | Curr Drug Targets | Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism. | 2015 | Details |
| A20326 | 26028039 | Curr Drug Targets | IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. | 2015 | Details |
| A20327 | 26027904 | Biochim Biophys Acta | Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. | 2015 | Details |
| A20328 | 26027765 | Diagn Interv Radiol | Imaging patterns of fatty liver in pediatric patients. | 2016 | Details |
| A20330 | 26026390 | Gastroenterology | High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. | 2015 | Details |
| A20331 | 26026214 | Nutr Metab Cardiovasc Dis | A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. | 2015 | Details |
| A20332 | 26025327 | J Nutr Biochem | Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome. | 2015 | Details |
| A20335 | 26024975 | Endocrine | Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? | 2015 | Details |
| A20336 | 26024755 | Metabolism | Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease. | 2015 | Details |
| A20337 | 26024397 | Rocz Panstw Zakl Hig | Health effects of changes in the structure of dietary macronutrients intake in western societies. | 2015 | Details |
| A20339 | 26021775 | Saudi J Gastroenterol | γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly. | 2016 | Details |
| A20340 | 26021772 | Saudi J Gastroenterol | The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease. | 2016 | Details |
| A20341 | 26021488 | Diabetologia | Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial. | 2015 | Details |
| A20342 | 26020857 | Nanomedicine (Lond) | Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitis. | 2015 | Details |
| A20343 | 26020401 | Medicine (Baltimore) | Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study. | 2015 | Details |
| A20344 | 26020041 | Endosc Ultrasound | Endoscopic ultrasound-guided liver biopsy. | 2015 | Details |
| A20345 | 26019740 | World J Hepatol | Valproic acid and nonalcoholic fatty liver disease: A possible association? | 2015 | Details |
| A20346 | 26019735 | World J Hepatol | Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. | 2015 | Details |
| A20347 | 26019732 | World J Hepatol | Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. | 2015 | Details |
| A20348 | 26019451 | World J Gastroenterol | Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease. | 2015 | Details |
| A20349 | 26019445 | World J Gastroenterol | Liver involvement in pediatric celiac disease. | 2015 | Details |
| A20350 | 26019443 | World J Gastroenterol | Pathophysiology after pancreaticoduodenectomy. | 2015 | Details |
| A20352 | 26019041 | Ann Hepatol | Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model. | 2016 | Details |
| A20353 | 26019035 | Ann Hepatol | The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease. | 2016 | Details |
| A20354 | 26018881 | Sao Paulo Med J | Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). | 2015 | Details |
| A20355 | 26018806 | Mol Med | Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20356 | 26018346 | Mol Med Rep | Intrahepatic transplantation of adipose-derived stem cells attenuates the progression of non-alcoholic fatty liver disease in rats. | 2015 | Details |
| A20357 | 26017679 | Dig Dis Sci | Prevalence of Nonalcoholic Fatty Liver Disease and Economy. | 2015 | Details |
| A20358 | 26017539 | PLoS One | Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. | 2015 | Details |
| A20359 | 26017459 | Pediatr Blood Cancer | Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation. | 2015 | Details |
| A20360 | 26017330 | Mol Med Rep | Lycium ruthenicum extract alleviates high-fat diet-induced nonalcoholic fatty liver disease via enhancing the AMPK signaling pathway. | 2015 | Details |
| A20361 | 26017323 | Int J Food Sci Nutr | Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis. | 2015 | Details |
| A20362 | 26016715 | Diabetes | Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20363 | 26016461 | Hepatol Int | Pattern and profile of chronic liver disease in acute on chronic liver failure. | 2015 | Details |
| A20364 | 26015548 | Diabetes | Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice. | 2015 | Details |
| A20365 | 26013469 | J Nutr Biochem | Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing diet. | 2015 | Details |
| A20367 | 26011302 | Metab Syndr Relat Disord | Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20368 | 26011231 | Eur J Gastroenterol Hepatol | Increased abdominal fat levels measured by bioelectrical impedance are associated with histological lesions of nonalcoholic steatohepatitis. | 2015 | Details |
| A20369 | 26008803 | Diab Vasc Dis Res | Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes. | 2015 | Details |
| A20370 | 26006114 | Gut | Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. | 2015 | Details |
| A20371 | 26005678 | Hepatobiliary Surg Nutr | The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20372 | 26005677 | Hepatobiliary Surg Nutr | Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. | 2015 | Details |
| A20373 | 26005676 | Hepatobiliary Surg Nutr | Fatty liver disease in diabetes mellitus. | 2015 | Details |
| A20375 | 26004139 | Exp Gerontol | Aging impairs the hepatic subcellular distribution of ChREBP in response to fasting/feeding in rats: Implications on hepatic steatosis. | 2015 | Details |
| A20376 | 26003897 | Surg Obes Relat Dis | The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. | 2015 | Details |
| A20377 | 26003827 | J Endocrinol Invest | Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? | 2015 | Details |
| A20378 | 26003548 | Obes Surg | Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients. | 2015 | Details |
| A20379 | 26003186 | Eur J Nutr | Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice. | 2015 | Details |
| A20380 | 26002934 | Gut | Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study. | 2015 | Details |
| A20381 | 26001595 | Transl Res | High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis. | 2015 | Details |
| A20382 | 26000656 | Future Microbiol | Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. | 2015 | Details |
| A20383 | 26000287 | Biomed Res Int | Inhibitory effects of eucalyptus and banaba leaf extracts on nonalcoholic steatohepatitis induced by a high-fructose/high-glucose diet in rats. | 2015 | Details |
| A20384 | 25999863 | Front Physiol | The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. | 2015 | Details |
| A20385 | 25999428 | Am J Physiol Gastrointest Liver Physiol | The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. | 2015 | Details |
| A20386 | 25998863 | Ann N Y Acad Sci | Insulin resistance in clinical and experimental alcoholic liver disease. | 2015 | Details |
| A20389 | 25998209 | Hepatology | Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice. | 2015 | Details |
| A20390 | 25997043 | Medicine (Baltimore) | A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20391 | 25995986 | J Diabetes Metab Disord | Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients. | 2015 | Details |
| A20392 | 25994191 | Eur Radiol | Cost-utility analysis of nonalcoholic steatohepatitis screening. | 2015 | Details |
| A20393 | 25994073 | Diabetologia | Incretin-based therapies: where will we be 50 years from now? | 2015 | Details |
| A20394 | 25993881 | Expert Rev Gastroenterol Hepatol | Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives. | 2015 | Details |